U.S. Kitchen Cabinet Industry Needs Support Amid Unrelenting Import Surge
The U.S. kitchen cabinet industry has a long and storied history, deeply rooted in small- to medium-sized businesses that form the backbone of American manufacturing.
CPA Warns Senate Bill Contains Dangerous “Loophole” Benefiting China’s Solar Industry
CPA warned that the Senate version of President Trump’s reconciliation bill—known as the One Big Beautiful Bill—contains a critical loophole in both the Section 48E investment tax credit and 45Y production tax credit in the Inflation Reduction Act (IRA), creating an unintended but dangerous giveaway to China’s solar industry.
How to Make Tariffs Work for National Security, Enforcement, and Revenue
The two Trump Administrations have reshaped the debate on U.S. trade policy. For the first time in decades, U.S. officials are no longer endorsing the “free trade” orthodoxy that has contributed to the erosion of its manufacturing sector. Instead, tariffs are now the centerpiece of U.S. plans to repatriate supply chains and reindustrialize America.
Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet
America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicine. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe.
America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis
In the U.S. today, frontline cancer treatments are being rationed. ERs are short on sedatives. Amoxicillin—one of the most prescribed antibiotics in the country—has been in critical shortage. These are not temporary disruptions. They reflect a structural breakdown caused by the erosion of America’s pharmaceutical manufacturing base and a decades-long surge in generic drug imports.
Bessent Defends Tariffs in Senate Hearing, Calls Critics Sufferers of “Tariff Derangement Syndrome”
Treasury Secretary Scott Bessent stepped into somewhat hostile territory in the Senate Finance Committee hearing on Thursday. But despite dramatic criticism from Ranking Member Ron Wyden (D-OR) and other top Democrats on the Committee, Bessent took an early victory lap on tariffs.
Generic Drugs Need Government Support, House Health Subcommittee Admits
U.S. based generic drug makers need government support to expand – and maybe even to survive – the onslaught of imports nearly every member of the House Energy and Commerce Committee Subcommittee on Health said in a hearing on Wednesday.
Tariffs, Industrial Policies Like the CHIPS Act, Help Protect U.S. From ‘China Shock 2.0’
The second round of the early 2000s ‘China Shock’ will impact the rest of the world more than it will the United States. Tariffs and industrial policies – like the CHIPS Act and the Inflation Reduction Act – have somewhat protected the U.S. from China’s relentless exports.
Importers No Longer Loading Up on Goods as Tariff Reality Sinks In; April Imports Fall 16.3%
Importers slowed their buying frenzy that occurred prior to the ‘Liberation Day’ tariffs and now April’s trade figures show a not-surprising 16.3% drop for the month to $351 billion.
Sen. Kennedy Just Gave Howard Lutnick Best Example Why Reciprocal Tariffs Don’t Work
By the time the Committee hearing with Lutnick was over, it seemed pretty clear that the Trump administration has shifting ideas about reciprocity today, and are less sure about the nature of them than they were before “Liberation Day” on April 2.
